IA
AVXL icon

IFP Advisors’s Anavex Life Sciences AVXL Stock Holding History

IFP Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Buy
2,458
+368
+18% +$1.09K ﹤0.01% 3637
2026
Q1 		$6.42K Buy
2,090
+90
+5% +$390 ﹤0.01% 3388
2025
Q4 		$7.12K Hold
2,000
– – ﹤0.01% 3236
2025
Q3 		$17.8K Sell
2,000
-12
-0.6% -$122 ﹤0.01% 2639
2025
Q2 		$18.6K Buy
2,012
+10
+0.5% +$85 ﹤0.01% 2590
2025
Q1 		$17.2K Sell
2,002
-35
-2% -$330 ﹤0.01% 2355
2024
Q4 		$21.9K Buy
2,037
+37
+2% +$285 ﹤0.01% 2208
2024
Q3 		$11.4K Hold
2,000
– – ﹤0.01% 2373
2024
Q2 		$8.44K Hold
2,000
– – ﹤0.01% 2399
2024
Q1 		$10.2K Hold
2,000
– – ﹤0.01% 2228
2023
Q4 		$18.6K Hold
2,000
– – ﹤0.01% 1947
2023
Q3 		$13.1K Hold
2,000
– – ﹤0.01% 2148
2023
Q2 		$16.3K Hold
2,000
– – ﹤0.01% 2109
2023
Q1 		$2.9K Sell
2,000
-1,000
-33% -$9.98K ﹤0.01% 2774
2022
Q4 		$4K Sell
3,000
-1,000
-25% -$10.7K ﹤0.01% 3853
2022
Q3 		$5K Hold
4,000
– – ﹤0.01% 3995
2022
Q2 		$5K Hold
4,000
– – ﹤0.01% 3750
2022
Q1 		$5K Buy
4,000
+2,000
+100% +$24.6K ﹤0.01% 3750
2021
Q4 		$35K Hold
2,000
– – ﹤0.01% 1687
2021
Q3 		$36K Hold
2,000
– – ﹤0.01% 1712
2021
Q2 		$46K Hold
2,000
– – ﹤0.01% 1565
2021
Q1 		$30K Sell
2,000
-2,000
-50% -$21.8K ﹤0.01% 1658
2020
Q4 		$22K Hold
4,000
– – ﹤0.01% 1750
2020
Q3 		$18K Hold
4,000
– – ﹤0.01% 1684
2020
Q2 		$20K Hold
4,000
– – ﹤0.01% 1563
2020
Q1 		$12K Buy
+4,000
New +$13.9K ﹤0.01% 1686

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IFP Advisors's AVXL Position: Q2 2026 in Review

IFP Advisors increased its Anavex Life Sciences (AVXL) stake by 18% in Q2 2026, buying an estimated $1.09K and bringing the position to 2,458 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

IFP Advisors first reported a position in AVXL in Q1 2020 and has held it in 26 quarters since. The position peaked at $46K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • IFP Advisors held 2,458 shares of Anavex Life Sciences worth $6.37K as of Q2 2026.
  • IFP Advisors bought 368 Anavex Life Sciences shares in Q2 2026, an estimated $1.09K.
  • Anavex Life Sciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3637 holding.
  • IFP Advisors first reported a position in Anavex Life Sciences in Q1 2020 and has held it in 26 quarters since.
  • IFP Advisors's Anavex Life Sciences position peaked at $46K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.